Amos C. Hung

Amos C. Hung

Auto-generated profile, based on publicly available information

Amos C. Hung

Translational Research Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Cancer Letters
Verified
Journal Article
Closed access
AHAmos C. Hung
Amos C. Hung
CTChun-Hao Tsai
Chun-Hao Tsai
MHMing-Feng Hou
Ming-Feng Hou
WCWen-Lin Chang
Wen-Lin Chang
CWChie-Hong Wang
Chie-Hong Wang
Shyng-Shiou YuanShyng-Shiou Yuan
Shyng-Shiou Yuan

16 February 2009 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
DSDavid H. Small
David H. Small
RGRobert Gasperini
Robert Gasperini
AVAdele J. Vincent
Adele J. Vincent
AHAmos C. Hung
Amos C. Hung
LFLisa Foa
Lisa Foa
Although many of the biochemical mechanisms which regulate production or clearance of the amyloid-β protein (Aβ) of Alzheimer's disease (AD) are now well understood, the mechanism of Aβ neurotoxicity remains unclear. A number of studies have shown th

31 August 2016 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
AHAmos C. Hung
Amos C. Hung
SLSteven Lo
Steven Lo
MHMing-Feng Hou
Ming-Feng Hou
Yi-Chen LeeYi-Chen Lee
Yi-Chen Lee
CTChun-Hao Tsai
Chun-Hao Tsai
Shyng-Shiou YuanShyng-Shiou Yuan
Shyng-Shiou Yuan
Purpose: Visfatin is an adipocytokine involved in cellular metabolism, inflammation, and cancer. This study investigated the roles of extracellular visfatin in breast cancer, and explored underlying mechanisms in clinical and experimental settings. Experimental Design: Associations of serum visfatin with clinicopathologic characteristics and patient survival were assessed with Cox regression models and Kaplan–Meier analyses. Effects of extracellular visfatin on cultured breast cancer cells were examined, followed by in vivo investigation of tumor growth and metastasis in xenograft animal models. Imatinib and Stattic were used to inhibit c-Abl and STAT3 activation, respectively. Results: Breast cancer patients with high serum visfatin levels were associated with advanced tumor stage, increased tumor size and lymph node metastasis, and poor survival. Elevated phosphorylation of c-Abl and STAT3 in breast tumor tissues were correlated with high serum visfatin levels in patients. Visfatin-promoted in vitro cell viability and metastatic capability were suppressed by imatinib (c-Abl inhibitor) and Stattic (STAT3 inhibitor). Increased in vivo cell invasiveness was observed in zebrafish xenografted with visfatin-pretreated breast cancer cells. Tumor growth and lung metastasis occurred in visfatin-administered mice xenografted with breast cancer cells. Tail vein–injected mice with visfatin-pretreated breast cancer cells showed increased lung metastasis, which was suppressed by imatinib. Conclusions: Serum visfatin levels in breast cancer patients reveal potential prognostic values, and our findings that visfatin promoted breast cancer through activation of c-Abl and STAT3 may provide an important molecular basis for future design of targeted therapies that take into account different serum visfatin levels in breast cancer. Clin Cancer Res; 22(17); 4478–90. ©2016 AACR.

1 July 1999 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
SSSynthia H. Sun
Synthia H. Sun
LLLian‐Bin Lin
Lian‐Bin Lin
AHAmos C. Hung
Amos C. Hung
JKJon‐Son Kuo
Jon‐Son Kuo

26 November 2020 in Cancers
Verified
Journal Article
Open access
PDF file
YWYen-Yun Wang
Yen-Yun Wang
HCHuan Da Chen
Huan Da Chen
SLSteven Lo
Steven Lo
YCYu-Kwan Chen
Yu-Kwan Chen
YHYu-Ci Huang
Yu-Ci Huang
Shyng-Shiou YuanShyng-Shiou Yuan
Shyng-Shiou Yuan
Visfatin, an adipocytokine highly expressed in breast tumor tissues, is associated with breast cancer progression. Recent studies showed that adipocytokines mediate tumor development through adipocytokine tumor-stromal interactions in the tumor microenvironment. This study focused on the interaction between one key stromal constituent—tumor-associated macrophages—and visfatin. Pretreatment of THP-1 and peripheral blood mononuclear cells (PBMCs) with recombinant visfatin resulted in M2-polarization determined by CD163 and CD206 expression. Indirect co-culture with visfatin-treated THP-1 (V-THP-1) promoted the viability, migration, tumorsphere formation, EMT, and stemness of breast cancer cells. Cytokine array identified an increased CXCL1 secretion in V-THP-1 conditioned medium and recombinant CXCL1 enhanced cell migration and invasion, which were abrogated by the CXCL1-neutralizing antibody. Additionally, visfatin induced pERK in THP-1 cells and clinical samples confirmed a positive CXCL1/pERK correlation. In an orthotopic mouse model, the tumor bioluminescent signal of luciferase-expressing MDA-MB-231 (Luc-MDA-MB-231) cells co-cultured with V-THP-1 and the expression of proliferation marker Ki67 were significantly higher than that co-cultured with THP-1. Furthermore, tail vein-injected Luc-MDA-MB-231 pretreated with V-PBMCs conditioned medium metastasized to lungs more frequently compared to control, and this was reversed by CXCL1 blocking antibody. In summary, this study demonstrated that visfatin enhanced breast cancer progression via pERK/CXCL1 induction in macrophages.

1 June 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
YHYanling Hu
Yanling Hu
AHAmos C. Hung
Amos C. Hung
HCHao Cui
Hao Cui
EDEdgar Dawkins
Edgar Dawkins
MBMarta Bolós
Marta Bolós
DSDavid H. Small
David H. Small
The amyloid precursor protein (APP) is well studied for its role in Alzheimer disease. However, little is known about its normal function. In this study, we examined the role of APP in neural stem/progenitor cell (NSPC) proliferation. NSPCs derived from APP-overexpressing Tg2576 transgenic mice proliferated more rapidly than NSPCs from the corresponding background strain (C57Bl/6xSJL) wild-type mice. In contrast, NSPCs from APP knock-out (APP-KO) mice had reduced proliferation rates when compared with NSPCs from the corresponding background strain (C57Bl/6). A secreted factor, identified as cystatin C, was found to be responsible for this effect. Levels of cystatin C were higher in the Tg2576 conditioned medium and lower in the APP-KO conditioned medium. Furthermore, immunodepletion of cystatin C from the conditioned medium completely removed the ability of the conditioned medium to increase NSPC proliferation. The results demonstrate that APP expression stimulates NSPC proliferation and that this effect is mediated via an increase in cystatin C secretion.